W. Stephen Faraci

1.5k total citations
25 papers, 1.3k citations indexed

About

W. Stephen Faraci is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, W. Stephen Faraci has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Biochemistry and 5 papers in Pharmacology. Recurrent topics in W. Stephen Faraci's work include Antibiotic Resistance in Bacteria (5 papers), Amino Acid Enzymes and Metabolism (4 papers) and Biochemical and Molecular Research (4 papers). W. Stephen Faraci is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Amino Acid Enzymes and Metabolism (4 papers) and Biochemical and Molecular Research (4 papers). W. Stephen Faraci collaborates with scholars based in United States and United Kingdom. W. Stephen Faraci's co-authors include R. F. Pratt, Christopher J. Schmidt, Frank S. Menniti, Christopher T. Walsh, Frank Rusnak, Robin W. Spencer, Christopher T. Walsh, Bingwei Yang, R. A. VOLKMANN and Fredric J. Vinick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Reviews Drug Discovery.

In The Last Decade

W. Stephen Faraci

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Stephen Faraci United States 18 752 299 275 150 146 25 1.3k
Kak‐Shan Shia Taiwan 25 640 0.9× 282 0.9× 1.1k 3.9× 38 0.3× 91 0.6× 99 2.1k
John P. O’Donnell United States 20 671 0.9× 101 0.3× 146 0.5× 72 0.5× 135 0.9× 65 1.4k
Steven H. Olson United States 24 669 0.9× 221 0.7× 545 2.0× 271 1.8× 133 0.9× 47 1.7k
Norikazu Ohtake Japan 18 358 0.5× 135 0.5× 408 1.5× 72 0.5× 119 0.8× 57 1.0k
Susumu Shinagawa Japan 19 634 0.8× 97 0.3× 352 1.3× 57 0.4× 112 0.8× 40 1.0k
Andrea Mattarei Italy 25 896 1.2× 133 0.4× 164 0.6× 34 0.2× 199 1.4× 88 1.6k
Christophe Rochais France 22 643 0.9× 578 1.9× 561 2.0× 30 0.2× 193 1.3× 70 1.8k
Jichun Ma United States 12 463 0.6× 235 0.8× 283 1.0× 21 0.1× 90 0.6× 19 1.1k
Terry Rosen United States 23 1.1k 1.4× 349 1.2× 811 2.9× 122 0.8× 317 2.2× 31 1.8k
Daniel‐Henri Caignard France 24 666 0.9× 139 0.5× 945 3.4× 43 0.3× 216 1.5× 62 1.6k

Countries citing papers authored by W. Stephen Faraci

Since Specialization
Citations

This map shows the geographic impact of W. Stephen Faraci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Stephen Faraci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Stephen Faraci more than expected).

Fields of papers citing papers by W. Stephen Faraci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Stephen Faraci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Stephen Faraci. The network helps show where W. Stephen Faraci may publish in the future.

Co-authorship network of co-authors of W. Stephen Faraci

This figure shows the co-authorship network connecting the top 25 collaborators of W. Stephen Faraci. A scholar is included among the top collaborators of W. Stephen Faraci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Stephen Faraci. W. Stephen Faraci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menniti, Frank S., W. Stephen Faraci, & Christopher J. Schmidt. (2006). Phosphodiesterases in the CNS: targets for drug development. Nature Reviews Drug Discovery. 5(8). 660–670. 320 indexed citations
2.
Lowe, John, Robert A. Volkmann, Steven D. Heck, et al.. (1999). A new class of selective and potent inhibitors of neuronal nitric oxide synthase. Bioorganic & Medicinal Chemistry Letters. 9(17). 2569–2572. 15 indexed citations
3.
Chappie, Thomas A., A. DUNAISKIS, Anton Fliri, et al.. (1998). Synthesis, sar and pharmacology of CP-293,019: A potent, selective dopamine D4 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 8(7). 725–730. 28 indexed citations
4.
Faraci, W. Stephen, Stevin H. Zorn, Mark A. Sanner, & Anton Fliri. (1998). The discovery of potent and selective dopamine D4 receptor antagonists. Current Opinion in Chemical Biology. 2(4). 535–540. 9 indexed citations
5.
Chen, Yuhpyng L., Robert S. Mansbach, Steven M. Winter, et al.. (1997). Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine:  A Centrally Active Corticotropin-Releasing Factor1 Receptor Antagonist. Journal of Medicinal Chemistry. 40(11). 1749–1754. 93 indexed citations
6.
Faraci, W. Stephen, A. Nagel, Lawrence A. Vincent, et al.. (1996). 2‐Amino‐4‐methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo. British Journal of Pharmacology. 119(6). 1101–1108. 53 indexed citations
7.
Faraci, W. Stephen, et al.. (1995). Inhibition of Helicobacter pylori Urease by Phenyl Phosphorodiamidates: Mechanism of Action. Bioorganic & Medicinal Chemistry. 3(5). 605–610. 46 indexed citations
8.
Faraci, W. Stephen, Robin W. Spencer, Rebecca Williams, et al.. (1993). Inhibition of human leukocyte elastase (HLE) by novel bicyclic β-lactams. Bioorganic & Medicinal Chemistry Letters. 3(11). 2271–2276. 6 indexed citations
9.
Collins, J.L., et al.. (1992). CP-99,711: a non-peptide glucagon receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 2(9). 915–918. 29 indexed citations
10.
Vincent, Lawrence A., et al.. (1991). Novel in vitro and in vivo inhibitors of prolyl endopeptidase. Bioorganic & Medicinal Chemistry Letters. 1(11). 585–590. 7 indexed citations
11.
Faraci, W. Stephen & Christopher T. Walsh. (1989). Mechanism of inactivation of alanine racemase by .beta.,.beta.,.beta.-trifluoroalanine. Biochemistry. 28(2). 431–437. 59 indexed citations
12.
Rusnak, Frank, W. Stephen Faraci, & Christopher T. Walsh. (1989). Subcloning, expression, and purification of the enterobactin biosynthetic enzyme 2,3-dihydroxybenzoate-AMP ligase: demonstration of enzyme-bound (2,3-dihydroxybenzoyl)adenylate product. Biochemistry. 28(17). 6827–6835. 112 indexed citations
13.
Duncan, Kenneth, W. Stephen Faraci, Donald S. Matteson, & C T Walsh. (1989). (1-Aminoethyl)boronic acid: a novel inhibitor for Bacillus stearothermophilus alanine racemase and Salmonella typhimurium D-alanine:D-alanine ligase (ADP-forming). Biochemistry. 28(8). 3541–3549. 37 indexed citations
14.
Faraci, W. Stephen & Christopher T. Walsh. (1988). Racemization of alanine by the alanine racemases from Salmonella typhimurium and Bacillus stearothermophilus: energetic reaction profiles. Biochemistry. 27(9). 3267–3276. 36 indexed citations
15.
16.
17.
18.
Faraci, W. Stephen & R. F. Pratt. (1985). Mechanism of inhibition of the PC1 .beta.-lactamase of Staphylococcus aureus by cephalosporins: importance of the 3'-leaving group. Biochemistry. 24(4). 903–910. 63 indexed citations
19.
Pratt, R. F., W. Stephen Faraci, & Chandrika P. Govardhan. (1985). A direct spectrophotometric assay for d-alanine carboxypeptidases and for the esterase activity of β-lactamases. Analytical Biochemistry. 144(1). 204–206. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kak‐Shan Shia Breakdown of academic impact, for papers by John P. O’Donnell Breakdown of academic impact, for papers by Steven H. Olson Breakdown of academic impact, for papers by Norikazu Ohtake Breakdown of academic impact, for papers by Susumu Shinagawa Breakdown of academic impact, for papers by Andrea Mattarei Breakdown of academic impact, for papers by Christophe Rochais Breakdown of academic impact, for papers by Jichun Ma Breakdown of academic impact, for papers by Terry Rosen Breakdown of academic impact, for papers by Daniel‐Henri Caignard
Rankless by CCL
2026